444 related articles for article (PubMed ID: 25459105)
1. Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
Claassen DO; van den Wildenberg WP; Harrison MB; van Wouwe NC; Kanoff K; Neimat JS; Wylie SA
Pharmacol Biochem Behav; 2015 Feb; 129():19-25. PubMed ID: 25459105
[TBL] [Abstract][Full Text] [Related]
2. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
[TBL] [Abstract][Full Text] [Related]
3. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
[TBL] [Abstract][Full Text] [Related]
4. Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.
Leplow B; Sepke M; Schönfeld R; Pohl J; Oelsner H; Latzko L; Ebersbach G
J Neural Transm (Vienna); 2017 Feb; 124(2):217-225. PubMed ID: 27848033
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson's Disease.
Choi JH; Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho JW
Neurodegener Dis; 2019; 19(5-6):171-177. PubMed ID: 32454490
[TBL] [Abstract][Full Text] [Related]
7. Impulse Control and Related Disorders in Parkinson's Disease.
Weintraub D; Claassen DO
Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
[TBL] [Abstract][Full Text] [Related]
8. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
[TBL] [Abstract][Full Text] [Related]
9. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
[TBL] [Abstract][Full Text] [Related]
10. Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson Disease: Clinical Experience After 3 Years' Follow-up.
Todorova A; Samuel M; Brown RG; Chaudhuri KR
Clin Neuropharmacol; 2015; 38(4):132-4. PubMed ID: 26166238
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
12. Perceptual decision-making in patients with Parkinson's disease.
Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder.
Fantini ML; Macedo L; Zibetti M; Sarchioto M; Vidal T; Pereira B; Marques A; Debilly B; Derost P; Ulla M; Vitello N; Cicolin A; Lopiano L; Durif F
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):174-9. PubMed ID: 25006210
[TBL] [Abstract][Full Text] [Related]
14. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
15. The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
Kon T; Ueno T; Haga R; Tomiyama M
Brain Behav; 2018 Aug; 8(8):e01036. PubMed ID: 29956879
[TBL] [Abstract][Full Text] [Related]
16. Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease.
Bellosta Diago E; Lopez Del Val LJ; Santos Lasaosa S; López Garcia E; Viloria Alebesque A
Neurologia; 2017 Oct; 32(8):494-499. PubMed ID: 27087472
[TBL] [Abstract][Full Text] [Related]
17. Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease.
Obeso I; Wilkinson L; Jahanshahi M
Exp Brain Res; 2011 Sep; 213(4):435-45. PubMed ID: 21796541
[TBL] [Abstract][Full Text] [Related]
18. Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.
Baig F; Kelly MJ; Lawton MA; Ruffmann C; Rolinski M; Klein JC; Barber T; Lo C; Ben-Shlomo Y; Okai D; Hu MT
Neurology; 2019 Aug; 93(7):e675-e687. PubMed ID: 31311842
[TBL] [Abstract][Full Text] [Related]
19. [Impulsive-compulsive syndrome in Parkinson's disease].
Nikitina AV; Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
